Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Wayne P. Rothbaum | Director | $258M | +$45.8M | +21.6% | Mar 1, 2024 |
Merrill A. Mcpeak | Director | $5.66M | +$2.29M | +67.8% | Mar 1, 2024 |
Iain D. Dukes | Director | $1.32M | +$293K | +28.5% | Jun 11, 2024 |
Frederick G. Vogt | Interim CEO & General Counsel, Director | $1.3M | Jan 14, 2025 | ||
Raj K. Puri | Chief Regulatory Officer | $1.29M | Dec 16, 2024 | ||
Jean-Marc Bellemin | Chief Financial Officer | $522K | Sep 3, 2024 | ||
Ryan Maynard | Director | $488K | -$503K | -50.8% | Nov 12, 2024 |
Wendy L. Dixon | Director | $469K | Jun 10, 2022 | ||
Michael Weiser | Director | $413K | Jun 11, 2024 | ||
Wendy L. Yarno | Director | $413K | Jun 11, 2024 | ||
Athena Countouriotis | Director | $413K | Jun 11, 2024 | ||
Friedrich Graf | Chief Medical Officer | $376K | Jan 14, 2025 | ||
Igor Bilinsky | Chief Operating Officer | $346K | Jan 14, 2025 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|